USA Top 5 Web Medicine Providers Compared: Pricing, Strengths & Program Details (2026)
Independent landscape report comparing Hims & Hers, Ro, WeightWatchers Clinic, LifeMD, and Calibrate — membership fees, brand drug cash prices, dose strengths, and who each model fits.
14 min read · Updated 2026-07-30 · PureVital Learn
Snapshot: pricing & access
| Provider | Membership | Est. all-in cash | Insurance | Speed |
|---|---|---|---|---|
| #1 Hims & Hers | $39 first month, then ~$149/mo | ~$348–$598/mo (membership + brand GLP-1) | No (cash-pay platform) | Rx often 1–3 days |
| #2 Ro (Roman Body) | $39 first month, then ~$74–$149/mo Body membership | ~$273–$598/mo depending on membership tier + dose | No (cash-pay) | Rx often 1–3 days (+ Body onboarding step) |
| #3 WeightWatchers Clinic | From ~$25 first month (select plans) then ~$74/mo (12-mo) or ~$149/mo month-to-month | ~$74–$149 membership + med copay or ~$149–$449 cash drug | Yes — PA / Med+ navigation emphasized | Depends on clinician review + pharmacy partner fulfilment |
| #4 LifeMD | From ~$99/mo weight program (+ broader LifeMD membership tiers exist) | ~$248–$548/mo typical cash stack (membership + brand med) | Limited / plan-dependent (stronger on diabetes-indicated SKUs) | Often 3–7 days |
| #5 Calibrate | $199/mo (3-month minimum commitment = $597) | ~$199–$224/mo with coverage success; much higher if meds cash-pay | Required (commercial / employer; not Medicare/Medicaid focused) | Program onboarding + coverage navigation timeline |
Comparative scorecard (editorial)
Scores are relative rankings for clinic/patient evaluation — not medical endorsements. Higher = stronger on that axis within this set.
| Provider | Cash pricing | Strength / dose range | Price transparency | Clinical support layer |
|---|---|---|---|---|
| Hims & Hers | ●●●●● | ●●●●● | ●●●●● | ●●●●● |
| Ro (Roman Body) | ●●●●● | ●●●●● | ●●●●● | ●●●●● |
| WeightWatchers Clinic | ●●●●● | ●●●●● | ●●●●● | ●●●●● |
| LifeMD | ●●●●● | ●●●●● | ●●●●● | ●●●●● |
| Calibrate | ●●●●● | ●●●●● | ●●●●● | ●●●●● |
Medicine strength & cash-price reference (shared across platforms)
Platforms rarely invent unique strengths. They prescribe FDA-labeled products and pass through manufacturer cash programs. Use this table when comparing what each provider can titrate patients across.
| Medicine | Class | Listed strengths | Form | Direct cash band |
|---|---|---|---|---|
| Wegovy (semaglutide) injection | GLP-1 RA | 0.25, 0.5, 1.0, 1.7, 2.4 mg weekly; HD 7.2 mg | Single-use pen | ~$349/mo all standard doses; ~$399 HD; starter promo ~$199 |
| Wegovy pill (oral semaglutide) | GLP-1 RA oral | Titration up to 25 mg daily | Daily tablet | ~$149–$299/mo Novo cash channel |
| Zepbound (tirzepatide) | Dual GIP/GLP-1 | 2.5, 5, 7.5, 10, 12.5, 15 mg weekly | Single-dose vials or KwikPen | $299 (2.5) / $399 (5) / $449 (7.5–15) LillyDirect bands |
| Foundayo (orforglipron) | Oral non-peptide GLP-1 | 0.8, 2.5, 5.5, 9, 14.5, 17.2 mg daily | Daily capsule/tablet | ~$149–$349/mo by dose (LillyDirect) |
| Ozempic / Mounjaro | Diabetes-indicated brands | Label weekly ladders (semaglutide / tirzepatide) | Pens | Usually insurance-first; not interchangeable with weight brands legally/clinically |
Provider-by-provider detail
Rank #1
Hims & Hers
Cash-pay branded telehealth + membership
Pricing
- Membership: $39 first month, then ~$149/mo
- Medication: Manufacturer cash pricing (NovoCare / Lilly channels)
- Est. all-in: ~$348–$598/mo (membership + brand GLP-1)
- Insurance: No (cash-pay platform)
Best for
Patients who want fast branded access and accept cash-pay membership + drug totals.
Medicines offered
Wegovy (injection) · Wegovy pill · Zepbound · Foundayo (orforglipron) · Ozempic (select pathways)
Strength / dose detail on this platform
| Drug | Strengths | Cash band |
|---|---|---|
| Wegovy injection | 0.25, 0.5, 1.0, 1.7, 2.4 mg (HD 7.2 mg) | ~$349/mo standard; ~$399 HD; starter promo ~$199 (time-limited) |
| Wegovy pill | 1.5 → 4 → 9 → 25 mg daily | ~$149–$299/mo via Novo cash channels |
| Zepbound | 2.5–15 mg weekly (vial or KwikPen) | ~$299 / $399 / $449 by dose band (LillyDirect) |
| Foundayo | 0.8–17.2 mg daily oral | ~$149–$349/mo (LillyDirect dose bands) |
- Wegovy weekly pens: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg; HD 7.2 mg
- Wegovy oral: launch ladder up to 25 mg daily
- Zepbound weekly: 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg
- Foundayo oral: 0.8 → 2.5 → 5.5 → 9 → 14.5 → 17.2 mg
Highlights
- Largest US consumer telehealth GLP brand presence
- Shifted to branded-only after 2026 Novo settlement path
- Broad FDA-approved menu including oral options
- Fast onboarding and in-network shipping logistics
Watch-outs
- Membership auto-renews separately from drug cost
- No insurance billing on the platform fee
- All-in price rises quickly on higher maintenance doses
Rank #2
Ro (Roman Body)
Cash-pay branded Body Program + drug fulfilment
Pricing
- Membership: $39 first month, then ~$74–$149/mo Body membership
- Medication: Brand Wegovy / Zepbound / Foundayo at manufacturer cash bands
- Est. all-in: ~$273–$598/mo depending on membership tier + dose
- Insurance: No (cash-pay)
Best for
Patients who want coaching + branded orals/injectables in one consumer brand.
Medicines offered
Wegovy · Zepbound (LillyDirect integration) · Foundayo (launch partner)
Strength / dose detail on this platform
| Drug | Strengths | Cash band |
|---|---|---|
| Wegovy injection | 0.25–2.4 mg weekly (+ HD where available) | ~$199 intro / ~$349 standard / ~$399 HD |
| Zepbound | 2.5, 5, 7.5, 10, 12.5, 15 mg | ~$299–$449/mo via LillyDirect bands |
| Foundayo | 0.8–17.2 mg oral daily | ~$149–$349/mo dose-based |
- Full Wegovy injection titration ladder + oral Wegovy where offered
- Zepbound dose bands aligned to LillyDirect fulfilment
- Early Foundayo (orforglipron) carrier since Apr 2026
Highlights
- Strong Body Program coaching layer with GLP pathway
- Launch partner positioning for oral Foundayo
- Medical-grade onboarding and obesity-specialist oversight messaging
- Branded-only stance after exiting compounded inventory
Watch-outs
- Bundled program can obscure per-drug apples-to-apples cost
- Drug cost still separate from membership
- Cash-pay only
Rank #3
WeightWatchers Clinic
Clinic membership + brand meds via Novo/Lilly pharmacy partners
Pricing
- Membership: From ~$25 first month (select plans) then ~$74/mo (12-mo) or ~$149/mo month-to-month
- Medication: Not included — brand Wegovy / Zepbound / oral Wegovy via manufacturer channels or insurance
- Est. all-in: ~$74–$149 membership + med copay or ~$149–$449 cash drug
- Insurance: Yes — PA / Med+ navigation emphasized
Best for
Members who want behavioral coaching brand + insurance help for brand GLP-1s.
Medicines offered
Wegovy injection · Wegovy pill · Zepbound · Other non-GLP options as clinically appropriate
Strength / dose detail on this platform
| Drug | Strengths | Cash band |
|---|---|---|
| Wegovy injection | 0.25–2.4 mg weekly | NovoCare ~$349/mo (promos may lower starters) |
| Wegovy pill | Up to 25 mg oral | ~$149–$299/mo direct cash |
| Zepbound | 2.5–15 mg weekly | ~$299–$449/mo LillyDirect; insurance can be ~$25 with savings card |
- Wegovy injection titration to 2.4 mg (and higher dose offerings where available)
- Oral Wegovy pathway for needle-free preference
- Zepbound full weekly strength ladder when prescribed
Highlights
- Large consumer brand trust and behavioral Points® ecosystem
- Clinic model emphasizes insurance prior-authorization support
- Transparent that drug cost is separate from membership
- Multi-month plan discounts on clinic fee
Watch-outs
- Medication never “included” in advertised membership headlines
- Plan terms and auto-renew commitments vary
- Drug choice still depends on clinician + coverage
Rank #4
LifeMD
Lower membership + broad branded Rx menu
Pricing
- Membership: From ~$99/mo weight program (+ broader LifeMD membership tiers exist)
- Medication: Brand GLP / dual agonist cash or limited insurance pathways
- Est. all-in: ~$248–$548/mo typical cash stack (membership + brand med)
- Insurance: Limited / plan-dependent (stronger on diabetes-indicated SKUs)
Best for
Patients who may need diabetes-indicated brand options or a lower membership floor.
Medicines offered
Wegovy · Zepbound · Saxenda · Ozempic · Mounjaro · Foundayo (where listed)
Strength / dose detail on this platform
| Drug | Strengths | Cash band |
|---|---|---|
| Wegovy / Ozempic | Semaglutide weekly brand strengths per label | Wegovy NovoCare ~$349/mo; Ozempic varies by plan/pharmacy |
| Zepbound / Mounjaro | Tirzepatide 2.5–15 mg weekly bands | Zepbound LillyDirect ~$299–$449; Mounjaro insurance-first often |
| Saxenda | Liraglutide daily pen titration | Typically higher / less preferred vs weekly GLP-1s |
- Diabetes + obesity brand catalog (Ozempic/Mounjaro + Wegovy/Zepbound)
- Weekly injectable ladders matching manufacturer strengths
- Oral Foundayo where platform lists availability
Highlights
- Direct Novo partnership messaging for Ozempic/Wegovy access
- Wider molecule menu than pure Wegovy/Zepbound specialists
- Lower headline subscription than Hims ongoing rate
Watch-outs
- Slower start than Hims/Ro on many reports
- Two-step billing still applies
- Insurance helpfulness varies widely by plan
Rank #5
Calibrate
Insurance-first Metabolic Reset program (brand GLP-1s)
Pricing
- Membership: $199/mo (3-month minimum commitment = $597)
- Medication: Separate — aims for insurance copay (~$25 or less after deductible when covered)
- Est. all-in: ~$199–$224/mo with coverage success; much higher if meds cash-pay
- Insurance: Required (commercial / employer; not Medicare/Medicaid focused)
Best for
Insured patients who want a year-structured metabolic program with coaching.
Medicines offered
Wegovy · Zepbound · Ozempic · Mounjaro · Foundayo · other clinician-selected brand options
Strength / dose detail on this platform
| Drug | Strengths | Cash band |
|---|---|---|
| Brand GLP-1 / dual agonists | Label strengths for Wegovy / Zepbound / related brands | Prefer insurance; cash fallback = manufacturer bands + $199 program |
| Foundayo | Oral orforglipron dose ladder when prescribed | LillyDirect ~$149–$349 if paying cash beside program fee |
- Uses full FDA brand titration schedules (no compounded copies)
- Coaching + labs + curriculum wrapped around brand strengths
- 10%+ weight-loss guarantee language (see current terms)
Highlights
- Most coaching / curriculum-dense of the five
- Insurance navigation is a core product, not an add-on
- Brand-name only positioning
- Best fit when benefits verification succeeds
Watch-outs
- Highest program fee + commitment term
- Poor fit without commercial insurance
- Medication never included in the $199 headline
How to read the pricing math
- Platform fee — pays for intake, messaging, and program infrastructure.
- Drug fee — usually the same NovoCare / LillyDirect cash band (or an insurance copay when coverage lands).
- Dose band risk — higher maintenance strengths (e.g., Zepbound 7.5–15 mg at ~$449) drive most long-run cost.
- Commitment terms — Calibrate and some WW plans require multi-month enrollments.
Cheapest sticker is not always cheapest year: an insurance-navigated Calibrate plan at ~$199 + ~$25 med can undercut cash Hims/Ro stacks once coverage works — and the reverse is true when obesity meds are excluded from a plan.
Bottom-line recommendations
- Fast cash branded access: Hims & Hers or Ro.
- Insurance help + lifestyle brand: WeightWatchers Clinic.
- Broader brand menu / lower membership floor: LifeMD.
- Coaching-dense insured pathway: Calibrate.
- Lowest drug-only path (already prescribed): manufacturer-direct LillyDirect / NovoCare without a second membership layer.
Related reading
Clinical Weight Management in 2026: How PureVital GLP Options Support Sustainable Results
A practical guide to Semaglutide, Tirzepatide, Retatrutide, Orforglipron, and supportive clinic presentations — with strengths, forms, and when clinics choose each option.
12 min · 2026-04-05
Read
Semaglutide in Clinic Practice: Forms, Strengths, and Program Design
How clinics use PureVital Semaglutide vials, pens, oral capsules, sublingual drops, and the BPC-157 blend in structured weight programs.
9 min · 2026-04-08
ReadTirzepatide vs Semaglutide: Choosing Dual vs Single Pathway Options
A clinic-facing comparison of PureVital Tirzepatide and Semaglutide — mechanisms, presentations, and how teams decide between them.
8 min · 2026-04-10
Read